Login

Transport Infrastructure Group Before Discussing R&D Site Strategic Factors in Magny-les-Hameaux | Frédéric Gardès - CEO of Colas Group 00:10:00

Share On Facebook Share On Twitter

Frédéric Gardès is the CEO of Colas Group

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
AbitareIn CEO Marco Claudio Grillo on Expanding Milan's Residential Market | Marco Claudio Grillo, CEO , Abitare In SpA.
00:10:00
August 2024 Market Insights with Argonaut Capital: “Fighting The Fed”
00:10:00
Insights into API Price Trends & Business Strategy: Aarti Drugs CFO Discusses Market Outlook|Shri Adhish P. Patil,Chief Financial Officer & Chief Operating Officer,Aarti Drugs Ltd.
00:10:00
The role and application of investment platforms|Alexander Kalis,Co-Founder Managing Partner, Head of Investments,Milltrust International LLP
00:10:00
Future Trends in Family Office Investments for 2024: Insights from Scott H and Heidi Deer
00:10:00
Michael Underhill on Energy Independence and Real Asset Investing Amid Geopolitical Shifts
00:10:00
DOTD CEO Milan Patel and CFO Paraag Amin provide an overview of the company's full-year results for the period ending June 30, 2021, highlighting key operational achievements and financial performance, and outlining future focus areas​|Milan Patel, CEO of
00:10:00
Athanasios Papanikolaou and Vivartia's Agri-Food Leadership Part-2 | Athanasios Papanikolaou, CEO, Marfin Investment Group.
00:10:00
Disclosure: Securities and Advisory Services through M Holdings Securities and The L. Warner Companies
00:10:00
Technology's Role in Addressing Global Threats|Carey Smith, CEO, Parsons Corporation.
00:10:00
Christian Stendevad , CEO of Penneo outlines the company's European growth strategy, emphasizing digital solutions for client processes and KYC compliance.
00:10:00
Harmonic Inc company culture was rated poorly by employees, with CEO Patrick Harshman receiving an F (56/100), placing him in the bottom 5%.

© 2017 - Neuhu+